# US 2013/0273152 A1 · Anti-abuse pharmaceutical compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0273152 A1
- Document ID: US20130273152A1
- Status: Published application
- Kind: A1
- Application number: 13/641,091
- Filed: 2011-04-11
- Published: 2013-10-17
- Earliest claimed: 2010-04-14
- Assignees: Ayanda Group AS
- Inventors: Kurt Ingar Draget; Ingvild Johanne Haug; Steinar Johan Engelsen; Tore Seternes
- Web page: https://patentgrep.com/patent/US20130273152A1

## CPC

- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 25/00: Drugs for disorders of the nervous system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.

## Claims

### Claim 1

An oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.

### Claim 2 (depends on 1)

A composition as claimed in claim 1 wherein said oil comprises a fish or shellfish oil.

### Claim 3

A method of treatment of a mammalian subject (either human or non-human) by oral administration to said subject of an effective amount of a drug substance which is a drug of abuse, the improvement comprising administering said drug substance in a composition comprising a physiologically tolerable shell containing said drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.

### Claim 4

A pharmaceutical composition, for use in medicine, comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.

### Claim 5

A pharmaceutical composition, for use in treatment by oral administration of a condition responsive to a drug of abuse, comprising a physiologically tolerable shell containing said drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.

### Claim 6 (depends on 1, 2, 4, 5)

The use of a drug of abuse for the manufacture of a medicament as claimed in any one of claims 1, 2, 4 and 5 for use by oral administration in the treatment of a condition responsive to said drug of abuse.

### Claim 7

A composition, use or method as claimed in any of the preceding claims wherein said drug of abuse is an opioid, CNS depressant, or stimulant.

### Claim 8

A composition, use or method as claimed in any of the preceding claims wherein said drug of abuse is selected from the group consisting of codeine, morphine, hydrocodone, oxycodone, diamorphine, pethidine, tramadol, buprenorphine, propoxyphene, hydromorphone, meperidine, diphenoxylate, barbiturates (e.g. pentobarbital sodium), benzodiazepines (e.g. diazepam, alprazolam and flunitrazepam), amphetamines (e.g. amphetamine, dextroamphetamine, l-lysine-d-amphetamine), methyl phenidate, zolpidem, methadone, mephedrone, tetrahydrocannabinol, ketamine, clonidine, mexiletine, and tapentadol.
